Posaconazole 100mg gastro-resistant tablets
NHS hospitals in England used £64,819,449 of indicative cost of Posaconazole 100mg gastro-resistant tablets in the 12 months to July 2026, about 0.2% of all hospital medicines spend. That is up 5.1% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Posaconazole 100mg gastro-resistant tablets: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to July 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Posaconazole 100mg gastro-resistant tablets most
By indicative cost over the 12 months to July 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Guy's & St Thomas' Nhs Foundation Trust | £3,802,672 |
| Manchester University Nhs Ft | £2,948,770 |
| University College London Foundation Tr | £2,431,845 |
| The Royal Marsden Nhs Foundation Trust | £2,408,262 |
| Cambridge Univ Hosp Nhs Foundation Trust | £2,151,636 |
| King's College Hpl Nhs Foundation Trust | £1,945,327 |
| The Christie Nhs Foundation Trust | £1,930,200 |
| Western Sussex Hospitals Nhs Found Trust | £1,726,059 |
| University Hpls Of Leicester Nhs Trust | £1,656,032 |
| Univ Hpl B/Ham Nhs Foundation Trust | £1,650,881 |
The primary-care picture
Posaconazole is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Posaconazole medicine page.